These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18428624)

  • 1. Scintillation proximity assay.
    Kahl SD; Felder CC
    Curr Protoc Neurosci; 2005 Feb; Chapter 7():Unit 7.15. PubMed ID: 18428624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl sulfoxide: an antagonist in scintillation proximity assay [(35)S]-GTPgammaS binding to rat 5-HT(6) receptor cloned in HEK-293 cells?
    Mereghetti I; Cagnotto A; Mennini T
    J Neurosci Methods; 2007 Mar; 160(2):251-5. PubMed ID: 17049618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintillation proximity assay (SPA) technology to study biomolecular interactions.
    Cook N; Harris A; Hopkins A; Hughes K
    Curr Protoc Protein Sci; 2002 May; Chapter 19():Unit 19.8. PubMed ID: 18429228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors.
    Ferrer M; Kolodin GD; Zuck P; Peltier R; Berry K; Mandala SM; Rosen H; Ota H; Ozaki S; Inglese J; Strulovici B
    Assay Drug Dev Technol; 2003 Apr; 1(2):261-73. PubMed ID: 15090191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Configuring radioligand receptor binding assays for HTS using scintillation proximity assay technology.
    Carpenter JW; Laethem C; Hubbard FR; Eckols TK; Baez M; McClure D; Nelson DL; Johnston PA
    Methods Mol Biol; 2002; 190():31-49. PubMed ID: 12029825
    [No Abstract]   [Full Text] [Related]  

  • 6. Scintillation proximity assays in high-throughput screening.
    Glickman JF; Schmid A; Ferrand S
    Assay Drug Dev Technol; 2008 Jun; 6(3):433-55. PubMed ID: 18593378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha2-adrenergic agonist-induced inhibition of cyclic AMP formation in transfected cell lines using a microtiter-based scintillation proximity assay.
    Hancock AA; Vodenlich AD; Maldonado C; Janis R
    J Recept Signal Transduct Res; 1995; 15(1-4):557-79. PubMed ID: 8903964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of radioligand binding by scintillation proximity assay.
    Berry J; Price-Jones M
    Methods Mol Biol; 2005; 306():121-37. PubMed ID: 15867466
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetic analysis of inositol trisphosphate binding to pure inositol trisphosphate receptors using scintillation proximity assay.
    Patel S; Harris A; O'Beirne G; Cook ND; Taylor CW
    Biochem Biophys Res Commun; 1996 Apr; 221(3):821-5. PubMed ID: 8630045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
    Berry J; Price-Jones M; Killian B
    Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptor.
    Rodgers G; Hubert C; McKinzie J; Suter T; Statnick M; Emmerson P; Stancato L
    Assay Drug Dev Technol; 2003 Oct; 1(5):627-36. PubMed ID: 15090235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of scintillation proximity assay in drug discovery.
    Wu S; Liu B
    BioDrugs; 2005; 19(6):383-92. PubMed ID: 16392890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
    Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J
    Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay.
    Skinner RH; Picardo M; Gane NM; Cook ND; Morgan L; Rowedder J; Lowe PN
    Anal Biochem; 1994 Dec; 223(2):259-65. PubMed ID: 7887472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
    Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
    Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor.
    Heise CE; Sullivan SK; Crowe PD
    J Biomol Screen; 2007 Mar; 12(2):235-9. PubMed ID: 17208923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain.
    Nichols JS; Parks DJ; Consler TG; Blanchard SG
    Anal Biochem; 1998 Mar; 257(2):112-9. PubMed ID: 9514791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a homogeneous binding assay for histamine receptors.
    Crane K; Shih DT
    Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT6 receptor signal transduction second messenger systems.
    Codony X; Burgueño J; Ramírez MJ; Vela JM
    Int Rev Neurobiol; 2010; 94():89-110. PubMed ID: 21081203
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin--an intestinal secretagogue--receptor subtypes and intracellular mediators.
    Hansen MB
    Pharmacol Toxicol; 1995; 77 Suppl 1():3-39. PubMed ID: 7567786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.